DUAL PI3K δ/γ INHIBITOR RP6530 IN PATIENTS WITH...

Hematological Oncology 2017 / 06 Vol. 35

DUAL PI3K δ/γ INHIBITOR RP6530 IN PATIENTS WITH RELAPSED/REFRACTORY T-CELL LYMPHOMA: DOSE ESCALATION FINDINGS.

Oki, Y., Zain, J., Haverkos, B., Barde, P., Penmetsa, K., Huen, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_191
Date:
June, 2017
File:
PDF, 73 KB
english, 2017
Conversion to is in progress
Conversion to is failed